Mimedx Group, Inc. splits its revenue into 9 lines in its filings. The largest line in fiscal 2025, which ended Dec 31, 2025 was Wound at $276.3 million, 66% of the total.
USD in millions. The percent under a figure is the change from the year before.
| Line |
FY 2026
Sep 30, 2026
|
FY 2025
Dec 31, 2025
|
FY 2024
Dec 31, 2024
|
FY 2023
Dec 31, 2023
|
FY 2022
Dec 31, 2022
|
FY 2021
Dec 31, 2021
|
FY 2020
Dec 31, 2020
|
FY 2019
Dec 31, 2019
|
FY 2018
Dec 31, 2018
|
FY 2016
Dec 31, 2016
|
FY 2015
Dec 31, 2015
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
304
|
419
|
349
|
321
|
268
|
242
|
248
|
299
|
359
|
—
|
—
|
| Wound |
149
-42.6%
share 49.0%
|
276
share 66.0%
|
—
|
206
+16.9%
share 64.0%
|
176
share 65.7%
|
—
|
—
|
—
|
—
|
—
|
—
|
| Advanced Wound Care Tissue And Other |
—
|
—
|
—
|
—
|
—
|
216
+12.4%
share 89.4%
|
193
share 77.6%
|
—
|
—
|
—
|
—
|
| Hospital Site Of Service |
—
|
—
|
187
+0.2%
share 53.7%
|
187
+14.6%
share 58.2%
|
163
share 60.9%
|
—
|
—
|
—
|
—
|
—
|
—
|
| Surgical |
155
+15.3%
share 51.0%
|
142
+20.7%
share 34.0%
|
118
+1.8%
share 33.8%
|
116
+26.1%
share 36.0%
|
92
share 34.3%
|
—
|
—
|
—
|
—
|
—
|
—
|
| Private Office Site Of Service |
—
|
—
|
112
+17.3%
share 32.2%
|
96
+24.1%
share 29.8%
|
77
+3.5%
share 28.8%
|
75
share 30.8%
|
—
|
—
|
—
|
—
|
—
|
| Other Site Of Service |
—
|
—
|
49
+26.8%
share 14.1%
|
39
+40.8%
share 12.0%
|
27
share 10.3%
|
—
|
—
|
—
|
—
|
—
|
—
|
| Advanced Wound Care Umbilical Cord Derived |
—
|
—
|
—
|
—
|
—
|
24
+46.6%
share 9.8%
|
16
share 6.5%
|
—
|
—
|
—
|
—
|
| Section351 |
—
|
—
|
—
|
—
|
—
|
18
-44.7%
share 7.3%
|
32
share 12.8%
|
—
|
—
|
—
|
—
|
| Product And Service Other |
—
|
—
|
—
|
—
|
—
|
1
-87.3%
share 0.4%
|
8
share 3.1%
|
—
|
—
|
—
|
—
|
How these figures are calculated
Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- MDXG (Nasdaq)
- Fiscal year ends
- December 31
- Headquarters
- Marietta, GA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1376339
- Former names
- Alynx, Co. (until Apr 2, 2008)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.